3 Firms Steer Oncology Biotech's $350M Spinoff, IPO Plans
Legend Biotech, a clinical-stage biotechnology company being spun out of GenScript, said Friday it hopes to raise $350 million in an initial public offering steered by Cooley LLP, Harney Westwood &...To view the full article, register now.
Already a subscriber? Click here to view full article